New center for preparation and distribution of adult stem cells

June 24, 2003

Bethesda, MD -- The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today the award of a grant to Tulane University, in New Orleans, Louisiana, to establish a center for the preparation, quality testing, and distribution of adult stem cells.

The new center (established with a five-year grant totaling $4.3 million) will prepare and distribute a continuous supply of marrow stromal cells (MSCs) derived from adult human and rat bone marrow, respectively, using standardized protocols. Adult MSCs, also known as mesenchymal stem cells, are multipotential, non-hematopoietic stem cells that appear to have the capacity to differentiate into many different cell types, including bone, cartilage, neurons, and fat. Previous research has shown that when injected into animals whose bone marrow function has been altered, progeny of the MSCs populate several tissues, including bone, cartilage, lung, skin, liver, and brain.

Adult MSCs may be useful for cellular therapies for a number of diseases as well as for understanding basic features of stem cell biology, but these areas of research have been inhibited by the lack of standard MSC preparations that can be compared by different laboratories. To solve this problem, the Tulane center will prepare MSCs by the best current procedures using bone marrow collected on-site and will distribute the cells worldwide. The center also will derive MSCs from bone marrow preparations provided by individual laboratories and will return the cells to those laboratories for use in individual research programs.

"While the potential for adult stem cell research is great, the technical requirements and the expense of producing high-quality cells limit the capacity of investigators to proceed with their research," said Dr. Judith Vaitukaitis, Director of NCRR. "This center, with the emphasis on quality control and standardized methods, will move this promising research forward."

Adult stem cells have attracted increasing attention from researchers because they are readily isolated from individuals and can be expanded in culture and genetically engineered. The features of MSCs suggest that they may have many applications for cell and gene therapy.

Currently, donated organs and tissues can sometimes be used to replace ailing or damaged tissue, but the need for transplantable tissues and organs far outweighs the available supply. Adult MSCs, induced to differentiate into specific tissues either in vitro or in vivo, offer the possibility of a renewable resource of replacement cells to help treat diseases such as Parkinson's, Osteogenesis Imperfecta, and arthritis, as well as injuries to the spinal cord, heart and lung, among others. The availability of standardized preparations of both human and rat MSCs will allow scientists to better understand the capabilities of these cells for potential therapeutic uses in a number of different experimental systems.

The center has begun setting up operations and expects to announce its opening date shortly. Researchers may contact the center at

NCRR is part of the National Institutes of Health, an agency of the Department of Health and Human Services. NCRR is the nation's leading federal sponsor of resources that enable advances in many areas of biomedical research. NCRR support provides the scientific research community with access to a diverse array of biomedical research technologies, instrumentation, specialized basic and clinical research facilities, animal models, genetic stocks, and such biomaterials as cell lines, tissues, and organs.

NIH/National Center for Advancing Translational Sciences (NCATS)

Related Biomedical Research Articles from Brightsurf:

General data protection regulation hinders global biomedical research
The European Union (EU) General Data Protection Regulation (GDPR) was designed to give EU citizens greater protection and control of their personal data, particularly when transferred to entities outside the EU.

Novel educational program puts a human face on biomedical research
The goal of translational research is to speed research breakthroughs into clinical practice.

Biomedical research may miss key information by ignoring genetic ancestry
A new study of Black residents of four distinct US cities reveals variations in genetic ancestry and social status that underscore the inadequacy of using skin color as a proxy for race in research.

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.

World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.

Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

Read More: Biomedical Research News and Biomedical Research Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to